AzTrials
AzTrials

Non-cardiac SurgeryEuSOSNCT01203605

European Surgical Outcomes Study

An observational study of Non-cardiac Surgery, run by Queen Mary University of London at 28 sites in 28 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The European Surgical Outcomes Study (EuSOS) is a multi-centre, international cohort study of peri-operative care and clinical outcomes for patients undergoing non-cardiac surgery. Read more about this study

Who is it for?
Ages 16 years and older
Conditions the study is for
Non-cardiac Surgery
How many people
46,985 participants
Where
28 sitesin 28 countries
Study dates
Apr 2011to Jun 2011
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 years and older
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: In-patient adult non-cardiac surgery

Who may be able to join

  • Consecutive patients admitted to participating centres undergoing elective and non-elective non-cardiac surgery commencing during the seven day cohort period with a planned overnight stay

Who cannot join

  • patients undergoing planned day-case surgery
  • cardiac surgery
  • neurosurgery
  • radiological procedures
  • obstetric procedures

Trial locations and contacts

28 sites in 28 countries.

28 sites in 28 countries

Belgium1 site
  • National co-ordinator

    Ghent

Other trials in Belgium

Croatia1 site
  • National co-ordinator

    Zagreb

Other trials in Croatia

Cyprus1 site
  • National co-ordinator

    Nicosia

Other trials in Cyprus

Czechia1 site
  • National co-ordinator

    Brno

Other trials in Czechia

Denmark1 site
  • National co-ordinator

    Odense

Other trials in Denmark

Estonia1 site
  • National co-ordinator

    Tallinn

Other trials in Estonia

Finland1 site
  • National co-ordinator

    Helsinki

Other trials in Finland

France1 site
  • National co-ordinator

    Nîmes

Other trials in France

Germany1 site
  • National co-ordinator

    Berlin

Other trials in Germany

Greece1 site
  • National co-ordinator

    Athens

Other trials in Greece

Hungary1 site
  • National co-ordinator

    Pécs

Other trials in Hungary

Iceland1 site
  • National co-ordinator

    Reykjavik

Other trials in Iceland

Ireland1 site
  • National co-ordinator

    Mullingar

Other trials in Ireland

Italy1 site
  • National co-ordinator

    Udine

Other trials in Italy

Latvia1 site
  • National co-ordinator

    Riga

Other trials in Latvia

Lithuania1 site
  • National co-ordinator

    Vilnius

Other trials in Lithuania

Netherlands1 site
  • National co-ordinator

    Leeuwarden

Other trials in Netherlands

Norway1 site
  • National co-ordinator

    Bergen

Other trials in Norway

Poland1 site
  • National co-ordinator

    Poznan

Other trials in Poland

Portugal1 site
  • National co-ordinator

    Lisbon

Other trials in Portugal

Romania1 site
  • National co-ordinator

    Iași

Other trials in Romania

Serbia1 site
  • National co-ordinator

    Belgrade

Other trials in Serbia

Slovakia1 site
  • National co-ordinator

    Košice

Other trials in Slovakia

Slovenia1 site
  • National co-ordinator

    Ljubljana

Other trials in Slovenia

Spain1 site
  • National co-ordinator

    Valladolid

Other trials in Spain

Sweden1 site
  • National co-ordinator

    Malmö

Other trials in Sweden

Switzerland1 site
  • National co-ordinator

    Geneva

Other trials in Switzerland

United Kingdom1 site
  • National co-ordinator

    London

Other trials in United Kingdom

About this study

Official title: European Surgical Outcomes Study: A Multi-centre, International Seven Day Evaluation of Patient Care and Clinical Outcomes for Patients Undergoing Non-cardiac Surgery

The European Surgical Outcomes Study (EuSOS) is a multi-centre, international cohort study of peri-operative care and clinical outcomes for patients undergoing non-cardiac surgery.

Participating centres throughout Europe will contribute routine clinical data describing all eligible patients who undergo surgery from 4th April 2011 to 11th April 2011. Patients will then be followed until hospital discharge (or for a maximum of 60 days) for duration of hospital stay and hospital mortality. Routine clinical data will also be collected for those patients admitted to critical care at any stage after surgery but during the same hospital admission. Specific objectives are to describe clinical outcomes and standards of peri-operative care for patients undergoing non-cardiac surgery in Europe.

Read the detailed description

Research questions

  1. What is the in-hospital mortality rate for patients undergoing non-cardiac surgery in Europe?
  2. What is the duration of hospital stay for patients undergoing non-cardiac surgery in Europe?
  3. What is the current standard of peri-operative critical care provision for patients undergoing non-cardiac surgery in Europe?
  4. What is the current standard of haemodynamic (cardiac output) monitoring for patients undergoing non-cardiac surgery in Europe?
  5. Is there any evidence of differences in the standard of peri-operative care provision for patients undergoing non-cardiac surgery in different health-care systems within Europe?
  6. Is there any evidence of differences in hospital stay and mortality for patients undergoing major non-cardiac surgery in different health-care systems within Europe?
  7. What factors determine planned and unplanned admission to critical care after surgery?
  8. Are the factors associated with critical care admission similar to those associated with post-operative death?

Methods

International cohort study of all adult patients undergoing in-patient non-cardiac surgery from 4th April 2011 to 11th April 2011.

Centres

The investigators aim to recruit as many European centres as possible but anticipate that a minimum of 150 hundred centres in ten or more nations will be required.

Ethics approval

National co-ordinators will be responsible for clarifying the need for ethics approval and applying for this where appropriate. Centres will not be permitted to record data unless ethics approval or an equivalent waiver is in place. This study is in effect a large scale clinical audit. The investigators expect that in most, if not every participating country, there will be no requirement for individual patient consent as all data will be anonymised and is already recorded as part of routine clinical care.

Data collection

Data will be collected describing all eligible patients undergoing surgery within the seven day cohort period. These patients will then be followed up until hospital discharge. Data will then be fully anonymised and transcribed by local investigators onto an internet based electronic CRF. A centre specific form will be completed once for each hospital to provide data including university/non-university hospital, number of operating rooms, number and level of critical care beds, etc.

Data set

An operating room data sheet will be completed once for each patient recruited to include data describing patient factors (age, gender, American Society of Anesthesiologists grade, major co-morbid disease, etc), surgical factors (procedure category, grade and urgency of surgery, grade of surgeon, surgical checklist, etc), anaesthetic factors (anaesthetic technique, haemodynamic monitoring, airway, grade of anaesthetist, etc), post-operative care (post-operative recovery ward stay, post-operative invasive or non-invasive ventilation or inotrope within first 24 hours). A critical care data sheet will be completed once for each patient admitted to critical care at any time after surgery, to include data describing whether admission was planned or unplanned, organ support, SAPS III score and SOFA score etc). Patients will be followed until death or hospital discharge for the following outcomes: duration of critical care stay, critical care mortality, duration of hospital stay and in-hospital mortality.

Sample size calculation

The investigators anticipate that approximately 20,000 patients will be required to provide a sample of up to 2,000 admissions to critical care after surgery. Assuming an overall mortality rate following surgery of 1%, a sample size of 20,000 patients will yield 200 deaths. This will allow the inclusion of at least fifteen variables in a logistic regression model for mortality. The rate of admission to critical care is likely to vary between nations but an overall rate of 10% will yield data describing up to 2000 admissions to critical care, whilst an overall rate of 5% will yield 1000 admissions. This to allow construction of a robust logistic regression model for this outcome. 20,000 patients will also provide >99% confidence for the overall mortality rate with 0.37% confidence width. If 200 deaths are observed in an overall sample of 20,000 patients, the 99% confidence interval for the proportion would be (0.008 - 0.012) with a confidence width of 0.37%. This dataset would also have sufficient generalisability to inform the practice of peri-operative care on an international basis.

Statistical analysis

The data to be collected are all collected as part of routine clinical care. Categorical variables will be described as proportions and will be compared using chi-square or Fisher's exact test. Continuous variable will be described as mean and standard deviation if normally distributed or median and inter-quartile range if not normally distributed. Comparisons of continuous variables will be performed using one-way ANOVA or Mann-Whitney test as appropriate. Univariate analysis will be performed to test factors associated with planned and unplanned admission to critical care and / or in-hospital death. A multiple logistic regression model will be used to identify independent risk factors. A stepwise approach will be used to enter new terms into the logistic regression model where p<0.05 was set as the limit for inclusion of new terms. A logistic regression model will be performed to assess independent association between prognostic factors and outcomes. Results of logistic regression will be reported as adjusted odds ratios (OR) with 95% confidence intervals. A single final analysis is planned at the end of the study.

Organisation

The study will be conducted by the EuSOS study group on behalf of the European Society of Intensive Care Medicine and the European Society of Anaesthesiology. National co-ordinators will lead the project within individual nations and identify participating hospitals, translate study paperwork, distribute study paperwork and ensure necessary regulatory approvals are in place. Local co-ordinators will lead in the EuSOS study in individual institutions ensuring all relevant regulatory approvals are in place and adequate training of staff. They will supervise data collection, ensure timely data return and act as guarantor for the integrity and quality of data collected.

Keywords
Operative surgical procedures, mortality, adverse effects, Postoperative complications, Epidemiological Study
Medical subject headings
Postoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT01203605
Study groupRoleWhat they receive
In-patient adult non-cardiac surgeryConsecutive patients admitted to participating centres undergoing elective and non-elective non-cardiac surgery commencing during the seven day study period with a planned overnight stay. All eligible patients undergoing surgery within the seven day study period will be recruited wherever possible.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mortality

    Mortality prior to actual hospital discharge regardless of location censored at 60 days.

    Measured: In-hospital (maximum 60 days)

Secondary outcomes (5)
  1. Duration of hospital stay

    Time in days from day of surgery to actual hospital discharge regardless of location

    Measured: Within single hospital admission

  2. Planned admission to critical care

    Post-operative admission to critical care which was planned and agreed prior to surgery

    Measured: Within same hospital admission

  3. Unplanned admission to critical care

    Unplanned post-operative admission to critical care at any stage in the same hospital admission

    Measured: Within same hospital admission

  4. Duration of critical care stay

    Time in days from admission to critical care to actual discharge from critical care or death

    Measured: Within same hospital admission

  5. 28 day mortality

    Mortality up to 28 days after primary surgical procedure

    Measured: 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Sep 2010 (estimated)
  2. Study startApr 2011
  3. Primary completionJun 2011
  4. Study completionJun 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
46,985 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01203605
Sponsor's protocol ID
EuSOS 1.1
Acronym
EuSOS
Status last verified
Jun 2011
First submitted
15 Sep 2010
Last updated
5 Sep 2012
Results posted
No
Data monitoring committee
No

Publications

  • Ahmad T, Beilstein CM, Aldecoa C, Moreno RP, Molnar Z, Novak-Jankovic V, Hofer CK, Sander M, Rhodes A, Pearse RM. Variation in haemodynamic monitoring for major surgery in European nations: secondary analysis of the EuSOS dataset. Perioper Med (Lond). 2015 Sep 23;4:8. doi: 10.1186/s13741-015-0018-8. eCollection 2015.

    PubMed 26405521
  • van Zaane B, van Klei WA, Buhre WF, Bauer P, Boerma EC, Hoeft A, Metnitz P, Moreno RP, Pearse R, Pelosi P, Sander M, Vallet B, Pettila V, Vincent JL, Rhodes A; European Surgical Outcomes Study (EuSOS) group for the Trials groups of the European Society of Intensive Care Medicine and the European Society of Anaesthesiology. Nonelective surgery at night and in-hospital mortality: Prospective observational data from the European Surgical Outcomes Study. Eur J Anaesthesiol. 2015 Jul;32(7):477-85. doi: 10.1097/EJA.0000000000000256.

    PubMed 26001104
  • Jammer I, Ahmad T, Aldecoa C, Koulenti D, Goranovic T, Grigoras I, Mazul-Sunko B, Matos R, Moreno R, Sigurdsson GH, Toft P, Walder B, Rhodes A, Pearse RM; European Surgical Outcomes Study (EuSOS) group. Point prevalence of surgical checklist use in Europe: relationship with hospital mortality. Br J Anaesth. 2015 May;114(5):801-7. doi: 10.1093/bja/aeu460. Epub 2015 Jan 13.

    PubMed 25586728
  • Baron DM, Hochrieser H, Posch M, Metnitz B, Rhodes A, Moreno RP, Pearse RM, Metnitz P; European Surgical Outcomes Study (EuSOS) group for Trials Groups of European Society of Intensive Care Medicine; European Society of Anaesthesiology. Preoperative anaemia is associated with poor clinical outcome in non-cardiac surgery patients. Br J Anaesth. 2014 Sep;113(3):416-23. doi: 10.1093/bja/aeu098. Epub 2014 May 14.

    PubMed 24829444

Questions about this trial

What is this clinical trial studying?

An observational study of Non-cardiac Surgery, run by Queen Mary University of London at 28 sites in 28 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Sep 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 28 sites in Belgium, Croatia, Cyprus, Czechia, Denmark and 23 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mortality (time frame: In-hospital (maximum 60 days)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01203605, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Sep 2012.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in